Acute aortic dissection during sorafenib-containing therapy

Ann Oncol. 2010 Jan;21(1):181-2. doi: 10.1093/annonc/mdp468. Epub 2009 Oct 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antihypertensive Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Aortic Aneurysm / chemically induced*
  • Aortic Dissection / chemically induced*
  • Benzenesulfonates / adverse effects*
  • Capecitabine
  • Carcinoma, Renal Cell / drug therapy
  • Clinical Trials, Phase II as Topic
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Fluorouracil / analogs & derivatives
  • Gemcitabine
  • Humans
  • Hypertension / chemically induced
  • Kidney Neoplasms / drug therapy
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / adverse effects*
  • Sorafenib

Substances

  • Antihypertensive Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Deoxycytidine
  • Niacinamide
  • Capecitabine
  • Sorafenib
  • Fluorouracil
  • Gemcitabine